Older man sitting in recliner drinking coffee and smiling at a woman caregiver drinking coffee

Patient Assistance

Making a Difference for Those Who Matter Most

We believe that patients who need our medicine should have access to it.

Having financial difficulties paying for NUEDEXTA (Dextromethorphan HBr and Quinidine Sulfate) due to COVID-19 crisis? Learn more here.

Man in a wheelchair with someone's hand on his shoulder
Manufacturer Patient Assistance Program
  • Avanir has a Manufacturer Patient Assistance Program that provides free medication to uninsured and underinsured patients based on financial need and other eligibility criteria.

 

  • U.S. Healthcare Professionals:

To begin the program eligibility determination and enrollment process for your patient, please visit www.nuedextapatientassistance.com .

 

  • Patients:

To begin the program eligibility determination and enrollment process, please have your healthcare provider visit this website and use the above link to begin the application process.

 

  • For more information about our program, please call 855-468-3339.
A close up of a smiling man with glasses and a smiling woman looking at something together
Independent Charitable Foundations

There are additional independent resources and charities that may provide eligible patients with financial or other assistance to access their treatments. Consider the following organizations that may be able to help. Avanir is not associated with any of these organizations, and these organizations act independently of Avanir: 

Governance & Transparency
To truly serve patients, we must conduct our business with honesty and integrity. This extends to our governance teams, where ethical behavior and accurate reporting is required.
Learn More
Funding & Support
As part of our commitment to improving patient care, we offer funding to healthcare providers and other stakeholders to advance the field of CNS conditions.
Learn More
Working at Avanir
Become part of a diverse group of dedicated professionals at the forefront of developing treatments for CNS conditions in areas of unmet need, while honoring a high standard of integrity.
Learn More

MLR-AVN-US-0773-0622